A Quality Improvement Intervention Reduces the Time to Administration of Stat Medications.

Pediatr Qual Saf

Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Johns Hopkins Medicine Armstrong Institute for Patient Safety and Quality, Baltimore, Md.; Johns Hopkins University School of Medicine, Baltimore, Md.; and University of Hawaii School of Medicine, Honolulu, Hawaii.

Published: April 2017


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: The delivery of urgent ("stat") medications to hospitalized children is important for safe quality care. The goal of this study was to evaluate the effect of a set of interventions on the percentage of stat medications administered within 30 minutes of ordering.

Methods: A pre-post study in 2 pediatric units (36 beds) in a private hospital in Saudi Arabia between January 2015 and September 2016. Interventions included structured communication requirements, introduction of a dedicated electronic inbox for stat medication orders sent by nurses to the pharmacy, and the use of a pink envelope for the delivery of stat medications. A multivariate logistic regression model was used to model percentage of medications administered within goal.

Results: Three hundred four stat orders met inclusion criteria. The proportion of orders meeting the 30-minute goal increased from a mean of 20% to a mean of 49% after the interventions ( < 0.001). In the final month of the study, compliance reached a peak of 67%. The mean turnaround time from ordering to the administration of the medication decreased from 59.7 to 40.7 minutes ( < 0.001). On multivariate analysis, medication type and unit-based availability of medications were statistically significant predictors of turnaround time. The odds of compliance being achieved was 0.3 times less if the medication was not available on the unit.

Conclusions: A set of interventions significantly increased the percentage of stat medications delivered within 30 minutes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132455PMC
http://dx.doi.org/10.1097/pq9.0000000000000021DOI Listing

Publication Analysis

Top Keywords

stat medications
16
set interventions
8
percentage stat
8
medications administered
8
turnaround time
8
medications
7
stat
6
quality improvement
4
improvement intervention
4
intervention reduces
4

Similar Publications

Count outcomes often occur in cluster randomized trials. Particularly in the context of epidemiology, the ratio of incidence rates has been used to assess the effectiveness of an intervention. In practice, cluster sizes typically vary across clusters, and sample size estimation based on a constant cluster size assumption may lead to underpowered studies.

View Article and Find Full Text PDF

Objective: This research aimed at evaluating the effectiveness and safety of nitazoxanide and escitalopram as adjuvant therapies in patients with rheumatoid arthritis (RA).

Methods: In this randomized controlled parallel study, 90 patients with active RA were randomized into three groups; group 1 (control group; n = 30) which received traditional therapy, group 2 (Nitazoxanide group; n = 30) which received traditional therapy plus 1 gm/day oral nitazoxanide, and group 3 (Escitalopram group; n = 30) which received traditional therapy plus 10 mg/day oral escitalopram for three months. At baseline and 3 months after treatment, clinical and functional assessments were done through the 28-joint count disease activity score using C-reactive protein (DAS28-CRP), the health assessment questionnaire-disability index (HAQ-DI), and the patient's global assessment (PGA).

View Article and Find Full Text PDF

One important property of any drug product is its stability over time. A key objective in drug stability studies is to estimate the shelf-life of a drug, involving a suitable definition of the true shelf-life and the construction of an appropriate estimate of the true shelf-life. Simultaneous confidence bands (SCBs) for percentiles in linear regression are valuable tools for determining the shelf-life in drug stability studies.

View Article and Find Full Text PDF

Testing for Similarity of Dose Response in Multiregional Clinical Trials.

Stat Med

September 2025

Statistical Methodology, Novartis Pharma AG, Basel, Switzerland.

This article addresses the problem of determining whether the dose response relationships between subgroups and the full population in a multiregional trial are similar. Similarity is assessed in terms of the maximal deviation between the dose response curves. We consider a parametric framework and develop two powerful bootstrap tests: one for assessing the similarity between the dose response curves of a single subgroup and that of the full population, and another for comparing the dose response curves of multiple subgroups with that of the full population.

View Article and Find Full Text PDF

Objective: To estimate the prevalence of various hemoglobinopathies among newborns, women in antenatal clinic and children presenting with signs and symptoms suggestive of sickle cell disease (SCD).

Methods: A hospital-based prospective study was conducted at a Centre of Excellence for SCD (COESCD). Dried blood spot (DBS) samples were collected for newborn screening using heel-prick and venous samples were used in the post-neonatal age group.

View Article and Find Full Text PDF